Armata Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • Armata Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.48M, a 82.4% increase year-over-year.
  • Armata Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$41.4M, a 30.5% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$69M, a 87% decline from 2022.
  • Armata Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.9M, a 59.4% decline from 2021.
  • Armata Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$23.2M, a 4.39% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$41.4M -$5.48M +$25.7M +82.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$67M $8.99M +$12.5M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$79.6M -$25M -$10.5M -72.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$69M -$19.8M -$9.53M -92.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$59.5M -$31.2M -$22.5M -262% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$37M -$3.55M +$5.67M +61.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$42.6M -$14.5M -$5.72M -65.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$36.9M -$10.3M -$4.27M -70.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$32.7M -$8.61M -$3.2M -59% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$29.5M -$9.22M -$3.02M -48.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$26.4M -$8.77M -$3.28M -59.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$23.2M -$6.05M +$577K +8.71% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$23.7M -$5.42M +$350K +6.07% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$24.1M -$6.19M -$1.48M -31.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$22.6M -$5.5M -$417K -8.21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$22.2M -$6.62M -$2.04M -44.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$20.1M -$5.77M +$1.19M +17.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$21.3M -$4.71M -$511K -12.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$20.8M -$5.08M -$1.34M -35.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$19.5M -$4.59M +$3.04M +39.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$22.5M -$6.96M -$4.18M -151% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$18.3M -$4.2M -$1.03M -32.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$17.3M -$3.74M -$605K -19.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$16.7M -$7.63M -$5.28M -224% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$11.4M -$2.77M -$1.99M -256% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$9.43M -$3.17M +$3.29M +51% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$12.7M -$3.13M +$112K +3.45% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 -$12.8M -$2.35M +$7.15M +75.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-25
Q3 2017 -$20M -$779K +$1.6M +67.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$21.6M -$6.46M -$2.61M -67.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$19M -$3.25M -$134K -4.31% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$18.8M -$9.5M -$7.27M -326% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-27
Q3 2016 -$11.6M -$2.38M -$7.81M -144% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$3.76M -$3.85M -$14.6M -136% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $10.9M -$3.11M +$11.4M +78.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$516K -$2.23M -$1.57M -236% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-27
Q3 2015 $1.05M $5.44M -$15.8M -74.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-27
Q2 2015 $16.8M $10.8M -$3.1M -22.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-27
Q1 2015 $19.9M -$14.5M -$3.19M -28.2% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-27
Q4 2014 $23.1M -$664K -$1.12M -245% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $24.2M $21.2M +$70M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$45.7M $13.9M +$28.5M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$74.2M -$11.3M -$9.66M -587% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
Q4 2013 -$64.6M $458K Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 -$48.8M Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-04-15
Q2 2013 -$14.6M Apr 1, 2013 Jun 30, 2013 10-Q/A 2015-04-15
Q1 2013 -$1.65M Jan 1, 2013 Mar 31, 2013 10-Q/A 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.